A common mechanism by which type 2A von Willebrand disease mutations enhance ADAMTS13 proteolysis revealed with a von Willebrand factor A2 domain FRET construct.

by Christopher J Lynch, Adam D Cawte, Carolyn M Millar, David Rueda, David A Lane
Published 2017-01-01